NCT05116553

Brief Summary

The aim of this study is to identify effective methodologies to help people to improve their awareness of change, motivation, self-confidence and self-efficacy, compliance in behavioral change and psychological well-being.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 11, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

November 11, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2022

Completed
Last Updated

January 21, 2022

Status Verified

January 1, 2022

Enrollment Period

2 months

First QC Date

October 26, 2021

Last Update Submit

January 20, 2022

Conditions

Keywords

MotivationSelf efficacy

Outcome Measures

Primary Outcomes (2)

  • Change in levels of General Self-Efficacy Scale-10 (GSE-10)

    GSE-10 test is a validated test for the detection of general self efficacy. The total score ranges from 10 to 40. Higher scores mean better outcomes.

    Up to day 14

  • Change in levels of Basic Psychological Need Satisfaction and Frustration Scale (BPNSFS)

    The BPNSFP-24 test is a validated test for the detection of the satisfaction and frustration of the primary needs: autonomy, relatedness and competence (according to SDT Theory). The total score ranges from 24 to 120. Higher scores mean better outcomes.

    Up to day 14

Secondary Outcomes (2)

  • Change of the scales contained in the Depression Anxiety Stress Scales-21 (DASS-21)

    Up to day 14

  • Change in World Health Organisation-Five Well-Being Index (WHO-5)

    Up to day 14

Study Arms (2)

SDT (MI)

ACTIVE COMPARATOR

This group will receive standard 2 SDT (Self Determination Theory) psychological interviews.

Behavioral: SDT

SDT (MI) + CA

EXPERIMENTAL

This group will receive standard 2 SDT (Self Determination Theory) psychological interviews; moreover they will use an APP with a CA (Conversational Agent), an Artificial Intelligence.

Behavioral: SDTDevice: APP + CA

Interventions

SDTBEHAVIORAL

Standard 2 SDT (Self Determination Theory) psychological interviews.

SDT (MI)SDT (MI) + CA
APP + CADEVICE

An APP with a CA (Conversational Agent).

SDT (MI) + CA

Eligibility Criteria

Age50 Years - 67 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • whitecollar
  • a sufficient level of education to understand study procedures and be able to communicate with site personnel
  • to 70 years old

You may not qualify if:

  • \- current use of narcotics or other substances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Idego srl

Rome, 00197, Italy

Location

Study Officials

  • Tommaso Ciulli

    Idego srl

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pre-intervention test will be administered to the participants (T1) to assess their psychological well-being, motivation, awareness of change, self-confidence and self-efficacy. Participants will be randomly divided into two group: the experimental group will receive the standard 2 Self Determination Theory (SDT) psychological interviews with the support of the APP with the Conversational Agent (CA), while the control group will receive the 2 SDT (Self Determination Theory) psychological interviews. At the end of the pathway post-intervention test (T2) will be administered to the participants with the same questionnaire of the beginning.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2021

First Posted

November 11, 2021

Study Start

November 11, 2021

Primary Completion

December 31, 2021

Study Completion

January 20, 2022

Last Updated

January 21, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will share

Clinical data obtained from psychological testing and socio-demographic data and any feedback collected during the trial will be shared.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data will be available starting in February 2022
Access Criteria
The data available on the research website (www.co-adapt.it). A special page will be created where researchers can download the raw data to perform any analysis.

Locations